143 related articles for article (PubMed ID: 37119682)
1. Cerebellar ataxia with anti-mGluR1 auto-antibody in a pediatric patient: A case report.
Wang H; Yi B; Wang M; Wang Y; Wang S; Wang L; Song H; Fu J; Wang X; Cao L
J Neuroimmunol; 2023 May; 378():578082. PubMed ID: 37119682
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies.
Yoshikura N; Kimura A; Fukata M; Fukata Y; Yokoi N; Harada N; Hayashi Y; Inuzuka T; Shimohata T
J Neuroimmunol; 2018 Jun; 319():63-67. PubMed ID: 29685291
[TBL] [Abstract][Full Text] [Related]
3. Anti-mGluR1 encephalitis: Case illustration and systematic review.
Khojah O; Makkawi S; Alghamdi S
Front Neurol; 2023; 14():1142160. PubMed ID: 37139064
[TBL] [Abstract][Full Text] [Related]
4. [Cerebellar Ataxia and Autoantibodies].
Nanri K; Yoshikura N; Kimura A; Nakayama S; Otomo T; Shimohata T; Terashi H; Sato T; Yamada J
Brain Nerve; 2018 Apr; 70(4):371-382. PubMed ID: 29632285
[TBL] [Abstract][Full Text] [Related]
5. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against metabotropic glutamate receptor type 1 in a toddler with acute cerebellitis.
Bien CG; Braig S; Bien CI
J Neuroimmunol; 2020 Nov; 348():577366. PubMed ID: 32861169
[TBL] [Abstract][Full Text] [Related]
7. [Pediatric autoimmune encephalitis associated with anti-glutamic acid decarboxylase 65 antibody: two cases report and literature review].
Ren CH; Ren HT; Ren XT; Zhang WH; Li JW; Dai LF; Chen CH; Guan HZ; Fang F
Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):47-52. PubMed ID: 33397004
[No Abstract] [Full Text] [Related]
8. [Autoimmune cerebellar ataxia].
Nanri K; Okuma M; Sato S; Taguchi T; Tanaka N
Nihon Rinsho; 2015 Sep; 73 Suppl 7():632-7. PubMed ID: 26480769
[No Abstract] [Full Text] [Related]
9. Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis.
Poorthuis MHF; van Rooij JLM; Koch AH; Verdonkschot AEM; Leembruggen MM; Titulaer MJ
Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e579. PubMed ID: 31355315
[No Abstract] [Full Text] [Related]
10. Autoimmune Encephalitis With mGluR1 Antibodies Presenting With Epilepsy, but Without Cerebellar Signs: A Case Report.
Vinke AM; Zong S; Janssen JH; Correia-Hoffmann C; Mané-Damas M; Damoiseaux JGMC; de Vries JM; Pröpper D; Molenaar P; Losen M; Martinez Martinez P; Rouhl RPW
Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35450924
[TBL] [Abstract][Full Text] [Related]
11. Anti-dipeptidyl-peptidase-like protein 6 encephalitis with pure cerebellar ataxia: a case report.
Lin J; Zhu M; Mao X; Jin Z; Zhou M; Hong D
BMC Neurol; 2022 Jul; 22(1):242. PubMed ID: 35778696
[TBL] [Abstract][Full Text] [Related]
12. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis.
Spatola M; Petit Pedrol M; Maudes E; Simabukuro M; Muñiz-Castrillo S; Pinto AL; Wandinger KP; Spiegler J; Schramm P; Dutra LA; Iorio R; Kornblum C; Bien CG; Höftberger R; Leypoldt F; Titulaer MJ; Sillevis Smitt P; Honnorat J; Rosenfeld MR; Graus F; Dalmau J
Neurology; 2020 Dec; 95(22):e3012-e3025. PubMed ID: 32928978
[TBL] [Abstract][Full Text] [Related]
13. Hashimoto`s Encephalopathy Presenting with Progressive Cerebellar Ataxia.
Algahtani HA; Fatani AN; Shirah BH; Algahtani RH
Neurosciences (Riyadh); 2019 Oct; 24(4):315-319. PubMed ID: 31872812
[TBL] [Abstract][Full Text] [Related]
14. Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis.
Jarius S; Komorowski L; Regula JU; Haas J; Brakopp S; Wildemann B
J Neurol; 2022 Oct; 269(10):5420-5430. PubMed ID: 35624318
[TBL] [Abstract][Full Text] [Related]
15. [Novel Autoantibody-Related Encephalitis: anti-mGluR1 encephalitis, anti-IgLON5 disease, autoimmune GFAP astrocytopathy].
Yoshikura N; Kimura A; Shimohata T
Brain Nerve; 2021 May; 73(5):631-639. PubMed ID: 34006697
[TBL] [Abstract][Full Text] [Related]
16. Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies.
Zeniya S; Sanjo N; Kuwahara H; Ishikawa K; Higashi M; Matsunaga A; Yoneda M; Mizusawa H; Yokota T
Intern Med; 2022; 61(18):2793-2796. PubMed ID: 36104177
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
18. Anti-contactin-associated protein-like 2 antibody-associated cerebellar ataxia: A case report and literature review.
Wang J; Qiu Z; Li D; Dong H; Hao J; Liu Z
J Neuroimmunol; 2021 Apr; 353():577515. PubMed ID: 33640718
[TBL] [Abstract][Full Text] [Related]
19. Anti-GAD65 Antibody-Associated Autoimmune Encephalitis With Predominant Cerebellar Involvement Following Toripalimab Treatment: A Case Report of a Novel irAE of Toripalimab.
Zhou H; Xie X; Zhang T; Yang M; Zhou D; Yang T
Front Immunol; 2022; 13():850540. PubMed ID: 35401563
[TBL] [Abstract][Full Text] [Related]
20. [Hashimoto's encephalopathy presenting with isolated cerebellar ataxia in 13 children].
Liao YT; Chen WX; Hou C; Zhu HX; Chen LF; Zeng YR; Wu WX; Liang HC; Li XJ
Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):46-50. PubMed ID: 34986623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
